Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T20520 | Fosinopril | ||
Fosinopril, a phosphinic acid-containing angiotensin-converting enzyme inhibitor, is effective in hypertension treatment. Fosinopril is a prodrug that is converted to its active metabolite fosinoprilat. | |||
T1489 |
Fosinopril sodium
SQ28555,福辛普利钠 |
RAAS | Endocrinology/Hormones |
Fosinopril sodium 是一种血管紧张素转换酶(ACE)抑制剂的前药,能够作用于高血压和慢性心力衰竭。 | |||
T20518 |
Fosinoprilat
SQ-27,519,Fosinopril diacid,SQ 27,519,SQ27,519 |
||
Fosinoprilat, an active phosphinic acid metabolite of prodrug fosenopril, is activated by esterases in vivo. Fosinoprilat binds zinc with phosphinic acid group. | |||
T71205 |
Fosinopril-d7 sodium salt
|
||
Fosinopril-d7 is intended for use as an internal standard for the quantification of fosinopril by GC- or LC-MS. Fosinopril is a prodrug form of the angiotensin-converting enzyme inhibitor fosinoprilat. Oral administration of fosinopril inhibits angiotensin I-induced pressor responses in normotensive rats, dogs, and monkeys when administered at doses of 15, 15, and 10 µmol/kg, respectively. Fosinopril reduces fractional shortening and decreases left ventricular size in a porcine model of congesti... | |||
T71203 |
JBIR-22
|
||
JBIR-22 is a natural inhibitor for protein−protein interaction of the homodimer of proteasome assembly factor 3. |